Some Top-Rated Stocks Set Up As Market Falls Investor's Business Daily Alexion Pharmaceuticals (ALXN), whose specialty is treatments for cancer, auto-immunity disorders and transplant rejection, has built a 10-week base. The base shows a correction of just 14%, within the parameters of a flat base. |
